how was semaglutide discovered 30 years of obesity research and over 100 years of medical breakthroughs. Learn more about and the story behind the discovery here: https://lnkd.in/e_as9aKV | Novo Nordisk Discovery and Invention of Semaglutide

Individuals with a BMI of 25-29.9 may be a candidate if they have obesity related conditions such as high cholesterol, hypertension, etc

You dont need to overdo it one or two carrots daily is the sweet spot for consistent benefits without any risk of carotenemia

For non-diabetic users the question is whether both are needed: tirzepatide is far stronger for weight loss at 5 mg and above, while metformin is cheaper, oral, and more modest

1000mg Av

#BMS #Cobenfy #schizophrenia #psychiatry Biotech Executive, Thought Leader & Creator | Diagnostics Executive | Microfluidics & Immunoassay Innovation | FDA Strategy Led EUA 230055, EUA 240006 & 510(k) K240728 | Oncology, AIBiology & IVD Commercialization Market Watch | Bristol Myers Squibbs Cobenfy Faces Uptake Challenges Amid Strong Q3 Earnings Bristol Myers Squibb ($BMY) reported $12.2B in Q3 revenue, surpassing analyst expectations yet investor attention centered on Cobenfy, the first new schizophrenia drug in 35 years, which posted $43M in sales, slightly below forecasts